Literature DB >> 7259483

[Myoglobin radioimmunoassay: experience of the diagnosis of skeletal muscle disorders (author's transl)].

W R Kiessling, K W Pflughaupt.   

Abstract

Serum myoglobin was measured by a sensitive radioimmunoassay in healthy controls and in patients with skeletal muscle disorders such as polymyositis and Duchenne type muscular dystrophy. The serum myoglobin levels were closely related to the serum creatine kinase (CK) activity, thus indicating that myoglobin is a useful adjunct in the assessment of muscle cell damage.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7259483     DOI: 10.1007/bf00343766

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr (1970)


  6 in total

1.  Serum myoglobin level as diagnostic test in patients with acute myocardial infarction.

Authors:  M J Stone; M R Waterman; D Harimoto; G Murray; N Willson; M R Platt; G Blomqvist; J T Willerson
Journal:  Br Heart J       Date:  1977-04

2.  Serum levels of myoglobin and creatine kinase in Duchenne muscular dystrophy.

Authors:  W R Kiessling; R Beckmann
Journal:  Klin Wochenschr       Date:  1981-04-01

3.  Radioimmunoassays of human myoglobin in serum and urine.

Authors:  L E Roxin; P Venge; G Friman; R Hällgren
Journal:  Scand J Clin Lab Invest       Date:  1979-02       Impact factor: 1.713

4.  Radioimmunoassay for human myoglobin: methods and results in patients with skeletal muscle or myocardial disorders.

Authors:  K Miyoshi; S Saito; H Kawai; A Kondo; M Iwasa; T Hayashi; M Yagita
Journal:  J Lab Clin Med       Date:  1978-09

5.  Myoglobin concentrations and muscle-enzyme activities in serum after myocardial infarction and cardiac arrhythmia.

Authors:  T G Rosano; L A Sanders; E S Johnson; M A Kenny; K J Clayson; P E Strandjord
Journal:  Clin Chem       Date:  1977-05       Impact factor: 8.327

6.  The significance of the estimation of serum myoglobin in neuromuscular diseases.

Authors:  E A Hische; H J van der Helm
Journal:  J Neurol Sci       Date:  1979-10       Impact factor: 3.181

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.